TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20049561

Group type: EXPERIMENTAL
Intervention: Palonosetron (0.25 mg i.v.)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Granisetron (3 mg i.v.)
Number of subjects: 144
Study: 19288149

Group type: EXPERIMENTAL
Intervention: Sea buckthorn berries (SBB), 28 g daily for 3 months
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Sea buckthorn berries (SBB)
Number of subjects: 229
Study: 16979292

Group type: EXPERIMENTAL
Intervention: Active cTBS stimulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation (placebo)
Number of subjects: 20
Study: 15599835

Group type: EXPERIMENTAL
Intervention: Milrinone infusion for 48 to 72 hours
Number of subjects: 949

Group type: COMPARATOR
Intervention: Placebo infusion for 48 to 72 hours
Number of subjects: 949
Study: 11056773

Group type: EXPERIMENTAL
Intervention: Esmolol 100 micrograms/kg/min
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Esmolol 200 micrograms/kg/min
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 36
Study: 9300324

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Combination of amlodipine and hydrochlorothiazide
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Amlodipine or Hydrochlorothiazide or both
Number of subjects: 38
Study: 7944426

Group type: EXPERIMENTAL
Intervention: Postoperative intrahepatic arterial infusion with Farmorubicin and 5‐FU (i.a group)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no chemotherapy)
Number of subjects: 17
Study: 2976670

Group type: EXPERIMENTAL
Intervention: Enoximone (3 mg/kg oral and 1 mg/kg i.v.)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30100052

Group type: EXPERIMENTAL
Intervention: Low-moderate epinephrine doses
Number of subjects: 24
Study: 28185994

Group type: EXPERIMENTAL
Intervention: MI intervention to patients only
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: MI intervention to patients and caregivers
Number of subjects: 240

Group type: COMPARATOR
Intervention: Standard of care to patients and caregivers
Number of subjects: 240
Study: 25512674

Group type: EXPERIMENTAL
Intervention: Team captain‐led and poster STI screening promotion
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Sexual health adviser‐led and poster STI screening promotion
Number of subjects: 153

Group type: COMPARATOR
Intervention: Poster‐only STI screening promotion
Number of subjects: 153
Study: 23108378

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercises (PFME)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no PFME)
Number of subjects: 102
Study: 21962963

Group type: EXPERIMENTAL
Intervention: Dietary management
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Combined interventions (dietary management and physical exercise)
Number of subjects: 57

Group type: COMPARATOR
Intervention: All interventions (dietary management, physical exercise, or both)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Follow-up after 2.8 years
Number of subjects: 57
Study: 18251595

Group type: EXPERIMENTAL
Intervention: Pendulum appliance supported with a K‐loop buccally
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cervical headgear
Number of subjects: 30
Study: 16356485

Group type: EXPERIMENTAL
Intervention: CI-1034 (50mg BID)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CI-1034
Number of subjects: 0
Study: 15062137

Group type: EXPERIMENTAL
Intervention: Brachytherapy with supplemental external beam radiation therapy (XRT)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Brachytherapy without supplemental external beam radiation therapy (XRT)
Number of subjects: 213
Study: 11004287

Group type: EXPERIMENTAL
Intervention: Timolol GFS 0.5%
Number of subjects: 241

Group type: COMPARATOR
Intervention: Timoptic XE 0.5%
Number of subjects: 241
Study: 8645023

Group type: EXPERIMENTAL
Intervention: HCFU + DP
Number of subjects: 653

Group type: COMPARATOR
Intervention: HCFU
Number of subjects: 653
Study: 1333960

Group type: EXPERIMENTAL
Intervention: Urodilatin (4 micrograms kg‐1 bw, two high dose intravenous bolus injections at a 30 min interval, n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: ANF(99‐126) (4 micrograms kg‐1 bw, same dosing as Urodilatin, n = 6)
Number of subjects: 12
Study: 3870892

Group type: EXPERIMENTAL
Intervention: Stepped care participants attending clinic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HDFP participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants reporting side effects
Number of subjects: 0
Study: 30915366

Group type: EXPERIMENTAL
Intervention: Steroid injection combined with miniscalpel-needle (MSN) release
Number of subjects: 51

Group type: COMPARATOR
Intervention: Steroid injection alone
Number of subjects: 51
Study: 29355920

Group type: EXPERIMENTAL
Intervention: Mixed-mode survey designs (mail/web or web/mail)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Mail-only
Number of subjects: 275

Group type: COMPARATOR
Intervention: Web/mail
Number of subjects: 275

Group type: COMPARATOR
Intervention: Single-mode designs (mail-only/web-only)
Number of subjects: 275
Study: 26824795

Group type: EXPERIMENTAL
Intervention: 15-29 mmHg compression stocking (Stocking A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 8-16 mmHg compression stocking (Stocking B)
Number of subjects: 80
Study: 25040756

Group type: EXPERIMENTAL
Intervention: Tramadol 2 mg·kg(‐1) 6-hourly for up to 5 days
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo 6-hourly for up to 5 days
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 22147076

Group type: EXPERIMENTAL
Intervention: Adjuvant temozolomide (6 cycles)
Number of subjects: 0
Study: 20025149

Group type: EXPERIMENTAL
Intervention: NG‐nitro‐L‐arginine‐methyl‐ester (1 mg x kg(‐1))
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 17998767

Group type: EXPERIMENTAL
Intervention: Percutaneous balloon mitral valvuloplasty (PBMV)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (35 age- and gender-matched healthy volunteers)
Number of subjects: 60
Study: 15889234

Group type: EXPERIMENTAL
Intervention: Pioglitazone (15-45 mg/day)
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Gliclazide (80-320 mg/day)
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Metformin (850-2,550 mg/day)
Number of subjects: 1269
Study: 12485118

Group type: EXPERIMENTAL
Intervention: lansoprazole 60 mg once a day (qd)
Number of subjects: 67

Group type: COMPARATOR
Intervention: lansoprazole 30 mg twice a day (bid)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: NAB positive group
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: NAB negative group
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: NAB duration for H. pylori eradication group
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: NAB duration for H. pylori persistence group
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: H. pylori eradication group
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: H. pylori persistence group
Number of subjects: 67
Study: 9787889

Group type: EXPERIMENTAL
Intervention: Sertraline 100 mg daily
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 7649971

Group type: EXPERIMENTAL
Intervention: Higher-dose range nefazodone (100-600 mg/day)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo (2-6 capsules per day)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Lower-dose range nefazodone (50-300 mg/day)
Number of subjects: 240
Study: 2524219

Group type: EXPERIMENTAL
Intervention: Surfactant replacement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surfactant replacement and placebo
Number of subjects: 0
Study: 1221110

Group type: EXPERIMENTAL
Intervention: Ethanol (0.67 g/kg body weight) ingested at 0700
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ethanol (0.67 g/kg body weight) ingested at 1100
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ethanol (0.67 g/kg body weight) ingested at 1900
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ethanol (0.67 g/kg body weight) ingested at 2300
Number of subjects: 6
Study: 31942688

Group type: EXPERIMENTAL
Intervention: Banded OAGB
Number of subjects: 33

Group type: COMPARATOR
Intervention: Non-banded OAGB
Number of subjects: 33
Study: 31242001

Group type: EXPERIMENTAL
Intervention: Community Engagement and Planning (CEP)
Number of subjects: 1246

Group type: COMPARATOR
Intervention: Resources for Services (RS)
Number of subjects: 1246
Study: 28104470

Group type: EXPERIMENTAL
Intervention: CONNECT intervention (oncology nurse-led care management approach)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard oncology care
Number of subjects: 0
Study: 25772437

Group type: EXPERIMENTAL
Intervention: Cigarettes
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Marijuana
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Cocaine
Number of subjects: 152
Study: 23026869

Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 101

Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 21891985

Group type: EXPERIMENTAL
Intervention: Rinse containing miconazole nitrate (COFRM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rinse without miconazole nitrate (COFR)
Number of subjects: 0
Study: 19251144

Group type: EXPERIMENTAL
Intervention: SofPort Advanced Optics IOL with no aberration (no‐aberration IOL group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tecnis Z9000 IOL with negative spherical aberration (negative‐aberration IOL group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall ADVS score
Number of subjects: 0
Study: 17984346

Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Combination of rifampin and azithromycin
Number of subjects: 73

Group type: COMPARATOR
Intervention: Multivitamins (Control)
Number of subjects: 73
Study: 15213322

Group type: EXPERIMENTAL
Intervention: Bicarbonate/lactate-buffered PD fluid
Number of subjects: 14

Group type: COMPARATOR
Intervention: Conventional PD fluid
Number of subjects: 14
Study: 11694608

Group type: EXPERIMENTAL
Intervention: Medium-chain triacylglycerols (MCT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Long-chain triacylglycerols (LCT)
Number of subjects: 78
Study: 7525633

Group type: EXPERIMENTAL
Intervention: 0.02 mg/kg BW.day recombinant human GH (rhGH)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 3037812

Group type: EXPERIMENTAL
Intervention: RIT 4256 vaccine in adults
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: RIT 4256 vaccine in 6-month-old children
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: RIT 4256 vaccine in newborn infants
Number of subjects: 80

Group type: COMPARATOR
Intervention: RIT 4237 vaccine in newborn infants
Number of subjects: 80

Group type: COMPARATOR
Intervention: Comparison of RIT 4256 and RIT 4237 vaccines
Number of subjects: 80
Study: 30260251

Group type: EXPERIMENTAL
Intervention: 3 mL/kg of 3% HS (group L)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5 mL/kg of 3% HS (group H)
Number of subjects: 60
Study: 27165280

Group type: EXPERIMENTAL
Intervention: Prasugrel 5 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Prasugrel 10 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Prasugrel 10 mg and 5 mg
Number of subjects: 45
Study: 24892197

Group type: COMPARATOR
Intervention: VRC (pain control)
Number of subjects: 77

Group type: COMPARATOR
Intervention: VRD (distraction)
Number of subjects: 77
Study: 22112395

Group type: EXPERIMENTAL
Intervention: Clinical range symptoms on the attention problems scale of the CBCL
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Clinical range symptoms on the anxious/depressed scale of the CBCL
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Aggressive behavior symptoms (measured by CBCL)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Aggressive behavior
Number of subjects: 168
Study: 20724648

Group type: EXPERIMENTAL
Intervention: 25 mg alogliptin plus 30 mg pioglitazone (A25+P30)
Number of subjects: 655

Group type: COMPARATOR
Intervention: 25 mg alogliptin (A25)
Number of subjects: 655

Group type: COMPARATOR
Intervention: 30 mg pioglitazone (P30)
Number of subjects: 655
Study: 18772723

Group type: COMPARATOR
Intervention: Buffered saline (active control)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Viscous marketed artificial tear formulations (test formulation)
Number of subjects: 11
Study: 16260342

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (0.4 mg)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Vaginal misoprostol (0.8 mg)
Number of subjects: 97
Study: 12106840

Group type: EXPERIMENTAL
Intervention: Moderate intensity leg exercise (three 30-minute sessions/week) for 10 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sedentary lifestyle (control group)
Number of subjects: 58
Study: 10074978

Group type: EXPERIMENTAL
Intervention: Cytology plus cervicography
Number of subjects: 5550

Group type: COMPARATOR
Intervention: Cytology alone
Number of subjects: 5550
Study: 7674700

Group type: EXPERIMENTAL
Intervention: Ketoprofen solution (25 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ketoprofen tablet (2.5 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ketoprofen solution
Number of subjects: 16
Study: 2035779

Group type: EXPERIMENTAL
Intervention: Laryngeal mask anaesthesia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nasal mask anaesthesia
Number of subjects: 50
Study: 7012668

Group type: EXPERIMENTAL
Intervention: Allopurinol therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study: 31104280

Group type: EXPERIMENTAL
Intervention: 300 mg netupitant/0.5 mg palonosetron
Number of subjects: 30
Study: 29600390

Group type: EXPERIMENTAL
Intervention: Supervised technology-based levodopa monitoring
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unsupervised technology-based levodopa monitoring
Number of subjects: 20
Study: 26773983

Group type: EXPERIMENTAL
Intervention: Early spinal decompression (≤24 hours since trauma)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed spinal decompression
Number of subjects: 0
Study: 24570327

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) intravenous infusion of 20 ng/kg/min for 6 hours before and after contrast media administration
Number of subjects: 163

Group type: COMPARATOR
Intervention: 0.9% sodium chloride solution for routine hydration (control group)
Number of subjects: 163
Study: 22024226

Group type: EXPERIMENTAL
Intervention: PEG-IFN a-2b/RBV therapy (Secondary IFN group)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Non-secondary IFN group (Control)
Number of subjects: 54
Study: 19195791

Group type: EXPERIMENTAL
Intervention: AVPR1a RS3 repeat length
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: AVPR1a RS1 and RS3 polymorphisms
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Sex x RS3 interaction
Number of subjects: 113
Study: 17223306

Group type: EXPERIMENTAL
Intervention: Continuous iliofascial nerve sheath block (KT group) with 30 ml of ropivacaïne 4.75 mg/ml and 14 mg/h of ropivacaïne 2 mg/ml for 48 hours
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Continuous iliofascial nerve sheath block (KT group)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (NKT) with no iliofascial block
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (NKT)
Number of subjects: 21
Study: 16753936

Group type: EXPERIMENTAL
Intervention: Aortic valve-sparing operations (David I reimplantation technique, Gel-weave Valsalva graft)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Aortic valve-sparing operations
Number of subjects: 85
Study: 12648174

Group type: EXPERIMENTAL
Intervention: 50 microg misoprostol initially then a further identical dose 6 h later
Number of subjects: 191

Group type: COMPARATOR
Intervention: 2 mg dinoprostone initially followed by 1 mg 6 h later
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: 50 microg misoprostol
Number of subjects: 191

Group type: COMPARATOR
Intervention: 2 mg dinoprostone
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 191
Study: 10686630

Group type: EXPERIMENTAL
Intervention: Intervention to improve mother-child interaction
Number of subjects: 38

Group type: COMPARATOR
Intervention: Neurodevelopmental treatment (NDT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Cerebral palsy and developmental delays
Number of subjects: 38
Study: 8842782

Group type: EXPERIMENTAL
Intervention: Trimetazidine (60 mg initial dose followed by 20 mg tid for 5 days)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group (no trimetazidine)
Number of subjects: 169
Study: 1495860

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP) 1,000 micrograms daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (10 asthmatic children)
Number of subjects: 24
Study: 6406654

Group type: EXPERIMENTAL
Intervention: L-carnitine IV, 10 mg/kg . day
Number of subjects: 29

Group type: COMPARATOR
Intervention: No supplement (Control)
Number of subjects: 29
Study: 31189564

Group type: EXPERIMENTAL
Intervention: CoYoT1 (shared telemedicine appointments)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 42
Study: 29463485

Group type: EXPERIMENTAL
Intervention: Structured Bed Exercise (SBE)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study: 26902504

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone furoate (FF) and vilanterol (VI) combination therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhaled fluticasone furoate (FF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhaled vilanterol (VI)
Number of subjects: 0
Study: 24472827

Group type: EXPERIMENTAL
Intervention: Diet-specific Compensatory Health Beliefs (CHBs)
Number of subjects: 75
Study: 21385217

Group type: EXPERIMENTAL
Intervention: Slackline training (10 sessions)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 20662916

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Deionized water (control group)
Number of subjects: 13
Study: 17379475

Group type: EXPERIMENTAL
Intervention: Human albumin 20%
Number of subjects: 68

Group type: COMPARATOR
Intervention: Polygeline
Number of subjects: 68
Study: 15692889

Group type: EXPERIMENTAL
Intervention: Topical dexamethasone for one month (first week) and topical fluormetalone for the next three weeks
Number of subjects: 210

Group type: COMPARATOR
Intervention: Topical dexamethasone for one week
Number of subjects: 210
Study: 12458395

Group type: EXPERIMENTAL
Intervention: Thallium (Tl)
Number of subjects: 2560

Group type: EXPERIMENTAL
Intervention: Methoxyisobutylisonitrile (MIBI)
Number of subjects: 2560

Group type: EXPERIMENTAL
Intervention: Tetrofosmin (Tf)
Number of subjects: 2560
Study: 10204949

Group type: EXPERIMENTAL
Intervention: Total hip arthroplasty
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Hemiarthroplasty
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 7575117

Group type: EXPERIMENTAL
Intervention: Intensified follow-up
Number of subjects: 106

Group type: COMPARATOR
Intervention: Conventional follow-up
Number of subjects: 106
Study: 2267266

Group type: EXPERIMENTAL
Intervention: Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
Number of subjects: 28
Study: 7028533

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (25 mg for ages 2-5 years; 50 mg for ages 6-10 years)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 31541518

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A)
Number of subjects: 391
Study: 28062862

Group type: EXPERIMENTAL
Intervention: Conventional TENS
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Acupuncture-like TENS
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: High-voltage electrical stimulation
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Interferential current stimulation
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Diadynamic current
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 123
Study: 25614155

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.2 mg/day plus Serenoa repens 320 mg/day
Number of subjects: 140

Group type: COMPARATOR
Intervention: Tamsulosin 0.2 mg/day only
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 140
Study: 23617610

Group type: EXPERIMENTAL
Intervention: Nucleus(®) cochlear implant fitting suite
Number of subjects: 37

Group type: COMPARATOR
Intervention: Custom Sound™ methodology
Number of subjects: 37
Study: 21508862

Group type: EXPERIMENTAL
Intervention: Antipsychotic treatment (2 weeks and 4 weeks duration)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Unmedicated schizophrenia patients
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Antipsychotic treatment
Number of subjects: 22
Study: 19825324

Group type: EXPERIMENTAL
Intervention: Paliperidone immediate-release (IR) 1 mg dose
Number of subjects: 20
Study: 16869814

Group type: EXPERIMENTAL
Intervention: Continuous administration of cefotaxime (2 g over 24 h plus a loading dose of 1 g)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Intermittent administration of cefotaxime (1 g three times daily)
Number of subjects: 93
Study: 15200652

Group type: EXPERIMENTAL
Intervention: Ropivacaine (0.4%, 2 mg x kg(‐1))
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Ropivacaine (0.2%, 1 mg x kg(‐1)) plus ketamine (0.25 mg x kg(‐1))
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Ropivacaine (0.2%, 1 mg x kg(‐1)) plus tramadol (1 mg x kg(‐1))
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (Ropivacaine alone)
Number of subjects: 99
Study: 11158224

Group type: EXPERIMENTAL
Intervention: Cerivastatin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 12